Gastrointestinal Oncology Care in Bangalore

Multi-Disciplinary Gastrointestinal Oncology Care in Bangalore

The Gastrointestinal Oncology unit at IIGU Hospitals offers a highly integrated, compassionate, and state-of-the-art framework for the early detection, precise staging, and advanced management of digestive system malignancies. By combining endoscopic precision, cutting-edge surgical modalities, and targeted systemic therapies, our specialized tumor board approach ensures every patient receives an individualized, evidence-based treatment blueprint tailored for optimal recovery.

Gastrointestinal Cancers We Treat

Our dedicated oncology framework provides comprehensive medical, surgical, and therapeutic pathways for a broad spectrum of digestive tract malignancies:

Esophageal Cancer: Malignancies originating within the lining of the food pipe.
Stomach (Gastric) Cancer: Tumors developing inside the gastric mucosal linings.
Liver Cancer (Hepatocellular Carcinoma): Primary liver malignancies and metastatic hepatic conditions.
Pancreatic Cancer: Aggressive tumors affecting the exocrine or endocrine pancreatic structures.
Colorectal Cancer: Malignancies originating in the large intestine, colon, or rectum.
Gallbladder & Biliary Tract Cancers: Complex tumors of the gallbladder, bile ducts, and biliary tree.
Gastrointestinal Stromal Tumors (GIST): Specialized mesenchymal neoplasms arising within the GI tract walls.
Neuroendocrine Tumors (NETs): Hormone-producing cellular malignancies within the digestive tract or pancreas.

In-Depth Condition Guides, Symptoms & Advanced Treatment Tracks

1. Esophageal Cancer Care

Esophageal cancer arises from the inner mucosal layers of the food pipe. It is clinically correlated with prolonged tobacco usage, chronic alcohol consumption, severe obesity, and long-standing acid reflux (Barrett’s Esophagus). Because early-stage detection radically transforms survival metrics, immediate clinical evaluation of early warning signs is vital.

Common Symptoms: Progressive difficulty swallowing (dysphagia) that worsens over time, unintentional weight loss, persistent chest pain or pressure behind the breastbone, a chronic hacking cough, and unexplained hoarseness.
Precision Diagnosis: High-definition Upper GI Endoscopy paired with targeted tissue biopsies, advanced CT/PET Scans for microscopic staging, and Endoscopic Ultrasound (EUS) to accurately map tumor depth and localized lymph node involvement.
Tailored Treatment Modalities: Radical surgical resections (Esophagectomy) for clear resectable tumors, neoadjuvant or palliative Chemotherapy and Radiation, safe Endoscopic Mucosal Resection (EMR) for early surface lesions, and luminal Esophageal Stenting to provide palliative relief from physical obstructions.

2. Stomach (Gastric) Cancer Care

Gastric cancer typically originates within the cellular lining of the stomach. Significant risk factors include chronic Helicobacter pylori (H. pylori) bacterial infections, heavy smoking, and diets high in salted, smoked, or preserved foods. Routine clinical surveillance remains crucial for high-risk individuals.

Common Symptoms: Persistent indigestion, intractable heartburn, severe loss of appetite accompanied by rapid weight loss, recurrent nausea, vomiting, localized abdominal pain, or a constant feeling of fullness even after minimal food intake.
Tailored Treatment Modalities: Partial or total surgical removal of the stomach (Gastrectomy), perioperative or palliative Chemotherapy, targeted biological therapies for HER2-positive gastric disease, and advanced endoscopic interventions like EMR or Endoscopic Submucosal Dissection (ESD) for superficial tumors.

3. Liver Cancer (Hepatocellular Carcinoma / HCC)

Hepatocellular Carcinoma stands as the most prevalent primary liver cancer. It is highly correlated with underlying hepatic architecture changes, such as chronic liver cirrhosis, long-standing Hepatitis B or C infections, and severe Non-Alcoholic Fatty Liver Disease (NAFLD / NASH).

Common Symptoms: Persistent abdominal pain or a palpable hard mass in the right upper quadrant, unexplained weight loss, progressive yellowing of the skin and eyes (jaundice), chronic fatigue, and loss of appetite.
Tailored Treatment Modalities: High-precision Liver Resection (partial hepatectomy), evaluation for Liver Transplantation in select candidates, localized tumor destruction via Radiofrequency Ablation (RFA) or Microwave Ablation, advanced intra-arterial interventions like Transarterial Chemoembolization (TACE) or Transarterial Radioembolization (TARE), and cutting-edge Systemic Therapies including targeted agents and modern Immunotherapy.

4. Pancreatic Cancer Care

Pancreatic malignancies are clinically aggressive and frequently asymptomatic in their initial phases, making specialized diagnostic vigilance critical. Primary risk variables encompass long-term smoking, chronic diabetes mellitus, obesity, and hereditary or familial pancreatic traits.

Common Symptoms: Deep obstructive jaundice accompanied by dark tea-colored urine, unexplained severe weight loss, boring abdominal pain radiating directly into the back, and sudden-onset, difficult-to-manage diabetes.
Tailored Treatment Modalities: Complex surgical resection via the Whipple Procedure (Pancreaticoduodenectomy) or total/distal pancreatectomy, neoadjuvant or adjuvant Chemotherapy regimens, ERCP-guided biliary stenting to restore bile drainage, and proactive palliative care systems for pain tracking and symptom control.

5. Colorectal Cancer Care

Colorectal cancer generally originates as benign adenomatous polyps along the internal lining of the colon or rectum. Routine screening for individuals over the age of 45–50 is globally established as the premier defensive strategy to intercept and prevent malignant transformation.

Common Symptoms: Visible blood in the stool, persistent rectal bleeding, prolonged changes in bowel habits (alternating diarrhea and constipation), chronic abdominal cramping, weakness, and iron-deficiency anemia.
Tailored Treatment Modalities: Preventive endoscopic Polypectomy to excise precancerous growths, partial or total Colectomy (surgical colon resection), adjuvant or metastatic Chemotherapy tracks, and individualized Targeted Therapies or Immunotherapies determined by specific molecular and genetic profiling (e.g., MSI-H, MMR status).

6. Gallbladder & Biliary Tract Cancers

These uncommon malignancies manifest within the gallbladder or the complex branching network of the bile ducts (Cholangiocarcinoma). They tend to progress silently, frequently presenting in advanced stages with sudden biliary blockages.

Tailored Treatment Modalities: Aggressive Radical Surgery combining a cholecystectomy with localized liver resection and regional lymphadenectomy, therapeutic ERCP or Percutaneous Transhepatic Biliary Drainage (PTBD) with plastic or metal stenting to alleviate jaundice, and systemic Chemotherapy utilizing specialized Gemcitabine-based regimens.

7. Gastrointestinal Stromal Tumors (GIST)

GISTs represent a distinct category of mesenchymal tumors arising from the specialized interstitial cells of Cajal located within the muscular walls of the gastrointestinal tract (most commonly the stomach or small intestine).

Tailored Treatment Modalities: Complete surgical resection with negative margins for clear localized tumors, combined with targeted tyrosine kinase inhibitor (TKI) medical protocols using specialized medications like Imatinib or Sunitinib, supported by structured long-term radiological surveillance.

8. Neuroendocrine Tumors (NETs)

NETs originate from specialized hormone-producing neuroendocrine cells scattered throughout the digestive system and pancreas. These tumors can be functional, actively secreting hormones that generate distinct systemic syndromes.

Common Symptoms: Episodic skin flushing, chronic watery diarrhea, asthma-like wheezing, and intermittent abdominal cramping triggered by active hormone secretion into the bloodstream.
Tailored Treatment Modalities: Curative-intent Surgical Resection, symptom-blocking medical therapies using Somatostatin Analogues (such as Octreotide or Lanreotide), Peptide Receptor Radionuclide Therapy (PRRT) for advanced somatostatin-receptor-positive tumors, and targeted molecular therapies utilizing agents like Everolimus or Sunitinib.

Consult Our GI Oncology Specialists Today

Early screening, an accurate diagnosis, and an integrated multidisciplinary care approach are the most powerful factors in successfully treating digestive system cancers. If you or a family member are experiencing persistent digestive symptoms, require a diagnostic opinion, or want to explore advanced, minimally invasive treatment protocols, reach out to our team.

Take the first step toward advanced, dedicated care. Contact IIGU Hospitals today to book a comprehensive clinical consultation with our expert Gastrointestinal Oncology Tumor Board.